US 11944627
Methods for treating hematological malignancies and Ewing's sarcoma
granted A61KA61K31/44A61K31/445
Quick answer
US patent 11944627 (Methods for treating hematological malignancies and Ewing's sarcoma) held by Kura Oncology, Inc. expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Kura Oncology, Inc.
- Grant date
- Tue Apr 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/44, A61K31/445, A61K31/4523, A61K31/453